Replies to post #438472 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

nonsensical assertions ex

[flipper44]

Sorry Charlie, the trial wasn’t “over” until the last data was collected in August 2020.

Pazdur has publicly stated he’ll definitely “screw” (your word) with a trial design when continuing a placebo would be unethical. He’d even do it for evidence of tumor response differences, you must be absurd to think he wouldn’t do it for survival.

[sentiment_stocks]

NWBO tried for over a year to get the FDA to change their minds, but failed. Eventually NWBO changed the trial to call it over. As this change to the IND no longer had an ethical issue with patients signing the consent, the FDA lifted the hold. ~ exwannabe

Come on, man, at least throw an IMO in there.

[Goats'nCrows]

"...the FDA called it an ethical issue to do so."

The FDA "called it an ethical issue"? Can you help me out understanding your phrasing?

Is this an FDA practice?